Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.

作者: Qian Li , Julia D. Rempel , Terry B. Ball , Harold Aukema , Gerald Y. Minuk

DOI: 10.1007/S10620-020-06095-8

关键词:

摘要: Activation of innate immunity by gut-derived immunogens such as lipopolysaccharides (LPS) may play an important role in the pathogenesis nonalcoholic fatty liver disease (NAFLD). Whether NAFLD-associated lipid disturbances and polyunsaturated acid (PUFA) metabolism particular contribute to heightened immunity, remains be determined. To determine if oxylipins, metabolic products PUFA metabolism, enhance immune reactivity alone and/or following exposure LPS. Plasma peripheral blood mononuclear cells (PBMC) were collected from 35 NAFLD patients 8 healthy controls. Oxylipin levels documented HPLC–MS/MS, cytokines (IL-1, IL-6, IL-10, TNF-α) ELISA, chemokine receptors (CCR1 CCR2) flow cytometry. Mean plasma four pro-inflammatory oxylipins (Tetranor 12-HETE, 20-HETE, 8-HETrE, 7-HDoHE) significantly elevated compared However, did not correlate with severity injury reflected serum aminotransferases, ck18M30, Fib-4 determinations. In vitro, 20-HETE (0.01–100 nM), oxylipin most levels, alter or control PBMC cytokine release increases 24 h LPS exposure. Similarly, CCR1 CCR2 expression LPS-induced downregulation these receptors. Pro-inflammatory are increased NAFLD, but metabolites do appear drive short-term direct chemotaxis.

参考文章(29)
Alex Y Tan, Peter Zimetbaum, 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. Journal of Cardiovascular Pharmacology. ,vol. 57, pp. 294- 301 ,(2011) , 10.1097/FJC.0B013E3182073C78
Edward A. Dennis, Paul C. Norris, Eicosanoid storm in infection and inflammation Nature Reviews Immunology. ,vol. 15, pp. 511- 523 ,(2015) , 10.1038/NRI3859
Dominika Maciejewska, Piotr Ossowski, Arleta Drozd, Karina Ryterska, Dominika Jamioł-Milc, Marcin Banaszczak, Małgorzata Kaczorowska, Anna Sabinicz, Joanna Raszeja-Wyszomirska, Ewa Stachowska, Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease—A pilot study Prostaglandins & Other Lipid Mediators. ,vol. 121, pp. 184- 189 ,(2015) , 10.1016/J.PROSTAGLANDINS.2015.09.003
Thomas Luft, Michael Conzelmann, Axel Benner, Michael Rieger, Michael Hess, Ulrich Strohhaecker, Martin Görner, Ute Hegenbart, Anthony D. Ho, Peter Dreger, Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. ,vol. 110, pp. 4535- 4542 ,(2006) , 10.1182/BLOOD-2006-10-049817
Puneet Puri, Michelle M. Wiest, Onpan Cheung, Faridoddin Mirshahi, Carol Sargeant, Hae-Ki Min, Melissa J. Contos, Richard K. Sterling, Michael Fuchs, Huiping Zhou, Steven M. Watkins, Arun J. Sanyal, The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. ,vol. 50, pp. 1827- 1838 ,(2009) , 10.1002/HEP.23229
Alison L Groeger, Chiara Cipollina, Marsha P Cole, Steven R Woodcock, Gustavo Bonacci, Tanja K Rudolph, Volker Rudolph, Bruce A Freeman, Francisco J Schopfer, Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids Nature Chemical Biology. ,vol. 6, pp. 433- 441 ,(2010) , 10.1038/NCHEMBIO.367
Kouichi Miura, Ling Yang, Nico van Rooijen, Hirohide Ohnishi, Ekihiro Seki, Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 302, ,(2012) , 10.1152/AJPGI.00365.2011
Luca Miele, Venanzio Valenza, Giuseppe La Torre, Massimo Montalto, Giovanni Cammarota, Riccardo Ricci, Roberta Mascianà, Alessandra Forgione, Maria L. Gabrieli, Germano Perotti, Fabio M. Vecchio, Gianlodovico Rapaccini, Giovanni Gasbarrini, Chris P. Day, Antonio Grieco, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. ,vol. 49, pp. 1877- 1887 ,(2009) , 10.1002/HEP.22848